×

Antacids Market Size, Share, Trends, Growth Outlook

Antacids Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Tablet, Liquid, Others), By End-User (Hospital pharmacy, Retail pharmacy, Online pharmacy), Countries and Companies Report

  • Home
  • Healthcare
  • Antacids Market
  • |Published Month : November, 2024
  • |No. of Pages : 202

Antacids Market is estimated to increase at a growth rate of 5.1% CAGR over the forecast period from 2024 to 2030.

The Antacids Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Tablet, Liquid, Others), By End-User (Hospital pharmacy, Retail pharmacy, Online pharmacy).

An Introduction to Antacids Market in 2024

The Antacids Market in 2024 is witnessing steady growth, driven by the increasing prevalence of gastrointestinal disorders, growing demand for over-the-counter (OTC) medications, and advancements in antacid formulations to provide rapid relief from acid reflux, heartburn, and dyspepsia. Antacids are a class of medications that neutralize stomach acid and alleviate symptoms of acid-related disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers. With advancements in formulation technology, combination therapies, and product innovation, the market offers a variety of antacid formulations, including tablets, liquids, and chewable tablets, containing ingredients such as calcium carbonate, magnesium hydroxide, and aluminum hydroxide. Moreover, the integration of patient education, lifestyle modifications, and preventive measures further enhances symptom management, treatment adherence, and quality of life in individuals with acid-related gastrointestinal conditions.

Antacids Industry- Market Size, Share, Trends, Growth Outlook

Antacids Market Trend: Increasing Preference for Natural and Non-Systemic Antacids

An emerging trend in the Antacids market is the rising consumer preference for natural and non-systemic antacid formulations. With growing awareness about the potential side effects associated with long-term use of systemic antacids containing ingredients such as aluminum, calcium, and magnesium, consumers are seeking alternative options that provide relief from acid reflux and heartburn without disrupting the body's natural balance. This trend has led to a surge in demand for natural remedies like herbal antacids, plant-based formulations, and non-systemic antacid compounds that offer effective relief with reduced risk of adverse effects, driving innovation in the market.

Antacids Market Driver: Increasing Incidence of Gastrointestinal Disorders and GERD

A significant driver propelling the Antacids market is the increasing incidence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and dyspepsia worldwide. Factors such as unhealthy dietary habits, sedentary lifestyles, stress, obesity, and the rising prevalence of Helicobacter pylori infection contribute to the growing burden of acid-related disorders among the population. As a result, there is a heightened demand for over-the-counter (OTC) antacid medications to alleviate symptoms of acid reflux, heartburn, and indigestion, thereby fueling market growth.

Antacids Market Opportunity: Expansion of Product Portfolio and Enhanced Formulations

An opportunity in the Antacids market lies in the expansion of product portfolios and the development of enhanced formulations to cater to diverse consumer needs and preferences. Manufacturers have the opportunity to innovate and differentiate their offerings by introducing novel formulations with added functionalities such as rapid onset of action, longer duration of relief, improved taste profiles, and convenient dosage forms like chewable tablets, liquid suspensions, and effervescent powders. Additionally, there is potential for leveraging advanced drug delivery technologies such as microencapsulation, nanoemulsions, and gastroretentive systems to enhance the bioavailability and therapeutic efficacy of antacid ingredients, providing consumers with superior treatment options and driving market competitiveness.

Antacids Market Segmentation


By Type
Tablet
Liquid
Others
By End-user
Hospital pharmacy
Retail pharmacy
Online pharmacy
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Antacids Market Companies


Bayer AG
Boehringer Ingelheim International GmbH
Dr. Reddy’s Laboratories Ltd
GlaxoSmithKline plc
Pfizer Inc
Procter & Gamble
Reckitt Benckiser Group plc
Sanofi
Sun Pharmaceuticals Ltd
Takeda Pharmaceutical Company Ltd

 

 

Reasons to Buy the Antacids Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Antacids Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Antacids Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Antacids Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Antacids Market Size Outlook, $ Million, 2021 to 2030
3.2 Antacids Market Outlook by Type, $ Million, 2021 to 2030
3.3 Antacids Market Outlook by Product, $ Million, 2021 to 2030
3.4 Antacids Market Outlook by Application, $ Million, 2021 to 2030
3.5 Antacids Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Antacids Market Industry
4.2 Key Market Trends in Antacids Market Industry
4.3 Potential Opportunities in Antacids Market Industry
4.4 Key Challenges in Antacids Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Antacids Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Antacids Market Outlook By Segments
7.1 Antacids Market Outlook by Segments
By Type
Tablet
Liquid
Others
By End-user
Hospital pharmacy
Retail pharmacy
Online pharmacy

8 North America Antacids Market Analysis And Outlook To 2030
8.1 Introduction to North America Antacids Markets in 2024
8.2 North America Antacids Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Antacids Market size Outlook by Segments, 2021-2030
By Type
Tablet
Liquid
Others
By End-user
Hospital pharmacy
Retail pharmacy
Online pharmacy

9 Europe Antacids Market Analysis And Outlook To 2030
9.1 Introduction to Europe Antacids Markets in 2024
9.2 Europe Antacids Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Antacids Market Size Outlook By Segments, 2021-2030
By Type
Tablet
Liquid
Others
By End-user
Hospital pharmacy
Retail pharmacy
Online pharmacy

10 Asia Pacific Antacids Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Antacids Markets in 2024
10.2 Asia Pacific Antacids Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Antacids Market size Outlook by Segments, 2021-2030
By Type
Tablet
Liquid
Others
By End-user
Hospital pharmacy
Retail pharmacy
Online pharmacy

11 South America Antacids Market Analysis And Outlook To 2030
11.1 Introduction to South America Antacids Markets in 2024
11.2 South America Antacids Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Antacids Market size Outlook by Segments, 2021-2030
By Type
Tablet
Liquid
Others
By End-user
Hospital pharmacy
Retail pharmacy
Online pharmacy

12 Middle East And Africa Antacids Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Antacids Markets in 2024
12.2 Middle East and Africa Antacids Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Antacids Market size Outlook by Segments, 2021-2030
By Type
Tablet
Liquid
Others
By End-user
Hospital pharmacy
Retail pharmacy
Online pharmacy

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Bayer AG
Boehringer Ingelheim International GmbH
Dr. Reddy’s Laboratories Ltd
GlaxoSmithKline plc
Pfizer Inc
Procter & Gamble
Reckitt Benckiser Group plc
Sanofi
Sun Pharmaceuticals Ltd
Takeda Pharmaceutical Company Ltd

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Tablet
Liquid
Others
By End-user
Hospital pharmacy
Retail pharmacy
Online pharmacy

Frequently Asked Questions